Percutaneous retrogasserian glycerol rhizolysis in the management of trigeminal neuralgia

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Sixty patients with trigeminal neuralgia or atypical facial pain were followed for an average of 1 year after percutaneous retrogasserian glycerol rhizolysis. The procedure was initially effective in relieving pain in 80% of the patients with typical trigeminal neuralgia and symptomatic trigeminal neuralgia secondary to multiple sclerosis. However, life-table analysis indicated that 50% of this group had persistence or recurrence of pain within 18 months after the operation. Percutaneous retrogasserian glycerol rhizolysis was ineffective in relieving atypical trigeminal neuralgia or atypical facial pain. Minor complications occurred in 23% of patients, and major morbidity was seen in 1.6%. Facial sensory loss which persisted for more than 1 month was found in 72% of patients, corneal hypersthesia occurred in 15%, and an additional 7% had corneal anesthesia. The data indicate that the success of percutaneous retrogasserian glycerol rhizolysis in relieving trigeminal neuralgia is directly related to the production of facial sensory loss.

Original languageEnglish (US)
Pages (from-to)361-366
Number of pages6
JournalJournal of Neurosurgery
Volume69
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Trigeminal Neuralgia
Glycerol
Facial Pain
Pain
Life Tables
Neuralgia
Multiple Sclerosis
Anesthesia
Morbidity
Recurrence

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Percutaneous retrogasserian glycerol rhizolysis in the management of trigeminal neuralgia. / Burchiel, Kim.

In: Journal of Neurosurgery, Vol. 69, No. 3, 1988, p. 361-366.

Research output: Contribution to journalArticle

@article{17e87f87947a434bab13b4038565d889,
title = "Percutaneous retrogasserian glycerol rhizolysis in the management of trigeminal neuralgia",
abstract = "Sixty patients with trigeminal neuralgia or atypical facial pain were followed for an average of 1 year after percutaneous retrogasserian glycerol rhizolysis. The procedure was initially effective in relieving pain in 80{\%} of the patients with typical trigeminal neuralgia and symptomatic trigeminal neuralgia secondary to multiple sclerosis. However, life-table analysis indicated that 50{\%} of this group had persistence or recurrence of pain within 18 months after the operation. Percutaneous retrogasserian glycerol rhizolysis was ineffective in relieving atypical trigeminal neuralgia or atypical facial pain. Minor complications occurred in 23{\%} of patients, and major morbidity was seen in 1.6{\%}. Facial sensory loss which persisted for more than 1 month was found in 72{\%} of patients, corneal hypersthesia occurred in 15{\%}, and an additional 7{\%} had corneal anesthesia. The data indicate that the success of percutaneous retrogasserian glycerol rhizolysis in relieving trigeminal neuralgia is directly related to the production of facial sensory loss.",
author = "Kim Burchiel",
year = "1988",
language = "English (US)",
volume = "69",
pages = "361--366",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Percutaneous retrogasserian glycerol rhizolysis in the management of trigeminal neuralgia

AU - Burchiel, Kim

PY - 1988

Y1 - 1988

N2 - Sixty patients with trigeminal neuralgia or atypical facial pain were followed for an average of 1 year after percutaneous retrogasserian glycerol rhizolysis. The procedure was initially effective in relieving pain in 80% of the patients with typical trigeminal neuralgia and symptomatic trigeminal neuralgia secondary to multiple sclerosis. However, life-table analysis indicated that 50% of this group had persistence or recurrence of pain within 18 months after the operation. Percutaneous retrogasserian glycerol rhizolysis was ineffective in relieving atypical trigeminal neuralgia or atypical facial pain. Minor complications occurred in 23% of patients, and major morbidity was seen in 1.6%. Facial sensory loss which persisted for more than 1 month was found in 72% of patients, corneal hypersthesia occurred in 15%, and an additional 7% had corneal anesthesia. The data indicate that the success of percutaneous retrogasserian glycerol rhizolysis in relieving trigeminal neuralgia is directly related to the production of facial sensory loss.

AB - Sixty patients with trigeminal neuralgia or atypical facial pain were followed for an average of 1 year after percutaneous retrogasserian glycerol rhizolysis. The procedure was initially effective in relieving pain in 80% of the patients with typical trigeminal neuralgia and symptomatic trigeminal neuralgia secondary to multiple sclerosis. However, life-table analysis indicated that 50% of this group had persistence or recurrence of pain within 18 months after the operation. Percutaneous retrogasserian glycerol rhizolysis was ineffective in relieving atypical trigeminal neuralgia or atypical facial pain. Minor complications occurred in 23% of patients, and major morbidity was seen in 1.6%. Facial sensory loss which persisted for more than 1 month was found in 72% of patients, corneal hypersthesia occurred in 15%, and an additional 7% had corneal anesthesia. The data indicate that the success of percutaneous retrogasserian glycerol rhizolysis in relieving trigeminal neuralgia is directly related to the production of facial sensory loss.

UR - http://www.scopus.com/inward/record.url?scp=0023680517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023680517&partnerID=8YFLogxK

M3 - Article

VL - 69

SP - 361

EP - 366

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 3

ER -